Nova Eye Medical Limited (ASX:EYE)
Australia flag Australia · Delayed Price · Currency is AUD
0.1300
+0.0100 (8.33%)
May 9, 2025, 4:10 PM AEST

Nova Eye Medical Company Description

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.

The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter which offers malleability and manoeuvrability than common nylon alternatives; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration.

The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020.

Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Nova Eye Medical Limited
Nova Eye Medical logo
Country Australia
Founded 1970
Industry Medical Devices
Sector Healthcare
Employees 301
CEO Thomas Spurling

Contact Details

Address:
107 Rundle Street
Kent Town, 5067
Australia
Phone 61 8 8362 0193
Website nova-eye.com

Stock Details

Ticker Symbol EYE
Exchange Australian Securities Exchange
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU0000094252
SIC Code 3845

Key Executives

Name Position
Victor Previn Founder and Executive Chairman
Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D. MD and Executive Director
Kimberley Menzies Chief Financial Officer
Mark Flynn Investor Relations
Kate Hunt Chief Commercial Officer
Dr. David Lubeck M.D. Chief Medical Officer
Joaquin V. Wolff President of Ellex iTrack
Simon Jeremy Newton Gray BEc, C.A., CA Company Secretary
Don Watton Vice President of Global Service
Dr. Meera Verma B.Sc, FAICD, FTSE, M.Sc, Ph.D. Advisor to the Board